PETS PETMED EXPRESS INC
Data as of close
Consumer Defensive · Retail-Drug Stores And Proprietary Stores
PETMED EXPRESS INC (PETS) is a consumer defensive company in the Retail-Drug Stores And Proprietary Stores industry, with a market capitalization of $26 million. Shares last traded at $1.19, 70.8% below their 52-week high. Over the past year the stock is down 53.7%. Net profit margin is -17.3%, below the peer median of -0.2%. Revenue declined 21.1% year over year.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
PETS Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2026-03-31 | $0M | $0.00 | — |
| 2025-03-31 | $0M | $0.01 | — |
| 2024-03-31 | $12M | $0.61 | — |
| 2023-03-31 | $25M | $1.21 | 477% |
| 2022-03-31 | $24M | $1.20 | 130% |
| 2021-03-31 | $23M | $1.13 | 95% |
| 2020-03-31 | $22M | $1.09 | 84% |
| 2019-03-31 | $22M | $1.07 | 58% |
| 2018-03-31 | $17M | $0.85 | 47% |
| 2017-03-31 | $16M | $0.76 | 65% |
| 2016-03-31 | $15M | $0.72 | 71% |
| 2015-03-31 | $14M | $0.69 | 79% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2027 | -$0.28 | 2026-08-13 |
| Q4 2026 (derived) | -$0.18 | 2026-06-02 |
| FY 2026 | -$2.74 | 2026-06-02 |
| Q3 2026 | -$0.50 | 2026-02-05 |
| Q2 2026 | -$0.41 | 2025-12-19 |
| Q1 2026 | -$1.65 | 2025-12-19 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Retail-Drug Stores And Proprietary Stores peers
PETS vs 5 industry peers (Retail-Drug Stores And Proprietary Stores), by market cap. Data as of close
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.